ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 812 filers reported holding ISHARES TR in Q3 2023. The put-call ratio across all filers is 3.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $192,607 | -29.4% | 1,575 | -26.7% | 0.00% | -20.0% |
Q2 2023 | $272,964 | -1.7% | 2,150 | 0.0% | 0.01% | -16.7% |
Q1 2023 | $277,694 | -49.0% | 2,150 | -48.1% | 0.01% | -53.8% |
Q4 2022 | $544,198 | +16.3% | 4,145 | +3.6% | 0.01% | +8.3% |
Q3 2022 | $468,000 | -0.4% | 4,000 | 0.0% | 0.01% | +9.1% |
Q2 2022 | $470,000 | -13.6% | 4,000 | -4.3% | 0.01% | -8.3% |
Q1 2022 | $544,000 | -14.7% | 4,180 | 0.0% | 0.01% | -14.3% |
Q4 2021 | $638,000 | -49.6% | 4,180 | -46.7% | 0.01% | -51.7% |
Q3 2021 | $1,267,000 | -2.8% | 7,840 | -1.5% | 0.03% | -3.3% |
Q2 2021 | $1,303,000 | +30.0% | 7,960 | +19.6% | 0.03% | +11.1% |
Q1 2021 | $1,002,000 | -4.8% | 6,656 | -4.2% | 0.03% | -22.9% |
Q4 2020 | $1,052,000 | -83.4% | 6,946 | -85.1% | 0.04% | -86.1% |
Q3 2020 | $6,323,000 | +5.6% | 46,696 | +6.6% | 0.25% | +2.0% |
Q2 2020 | $5,989,000 | +552.4% | 43,822 | +414.5% | 0.25% | +412.5% |
Q1 2020 | $918,000 | -12.8% | 8,518 | -2.6% | 0.05% | +14.3% |
Q4 2019 | $1,053,000 | +35.0% | 8,743 | +11.6% | 0.04% | +35.5% |
Q3 2019 | $780,000 | -8.7% | 7,833 | 0.0% | 0.03% | -3.1% |
Q2 2019 | $854,000 | -15.9% | 7,833 | -13.8% | 0.03% | -8.6% |
Q1 2019 | $1,016,000 | -6.4% | 9,090 | -19.2% | 0.04% | -7.9% |
Q4 2018 | $1,085,000 | -26.5% | 11,255 | -7.0% | 0.04% | -9.5% |
Q3 2018 | $1,477,000 | -31.3% | 12,105 | -38.1% | 0.04% | -32.3% |
Q2 2018 | $2,149,000 | -13.7% | 19,570 | -16.1% | 0.06% | -13.9% |
Q1 2018 | $2,489,000 | +6.3% | 23,314 | +6.3% | 0.07% | +7.5% |
Q4 2017 | $2,342,000 | +31.3% | 21,940 | +310.3% | 0.07% | +31.4% |
Q3 2017 | $1,784,000 | +1437.9% | 5,347 | +1325.9% | 0.05% | +1600.0% |
Q2 2017 | $116,000 | +81.2% | 375 | +70.5% | 0.00% | +50.0% |
Q1 2017 | $64,000 | -74.4% | 220 | -76.6% | 0.00% | -71.4% |
Q4 2016 | $250,000 | +115.5% | 940 | +135.0% | 0.01% | +75.0% |
Q3 2016 | $116,000 | -7.9% | 400 | -18.4% | 0.00% | 0.0% |
Q2 2016 | $126,000 | +2.4% | 490 | +4.3% | 0.00% | 0.0% |
Q1 2016 | $123,000 | +17.1% | 470 | +51.6% | 0.00% | +33.3% |
Q4 2015 | $105,000 | +11.7% | 310 | 0.0% | 0.00% | +50.0% |
Q3 2015 | $94,000 | +154.1% | 310 | +210.0% | 0.00% | +100.0% |
Q2 2015 | $37,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |